Dr. Yajun Xu is a seasoned biotech investor with more than 20 years of senior management experience in Biotech and pharma. Yajun is currently a managing partner of Hongsen Capital, a co-founder of Epimab Inc., and serves as a board member and advisor for numerous biotech companies and investment firms…...
Albert Cheung-Hoi (CH) Yu, Ph.D.
Professor Albert CH Yu is a bio-entrepreneur and scientist with over 20 years of experience in the field. He has published over 170 peer review scientific papers and several commentaries in such publications as Science and Nature Biotechnology. Professor Yu is also the author of eight books and an inventor…...
Min Li, Ph.D.
Dr. Min Li is George Lynn Cross Research Professor of Medicine, Surgery, and Cell Biology at The University of Oklahoma Health Sciences Center (OUHSC), and holds the Virginia Kerley Cade Endowed Chair in Cancer Treatment. He is the Assistant Dean for International Research Collaboration at the College of Medicine, and…...
Kanaga Sabapathy, Ph.D.
Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995. After a post-doctoral stint at the Institute of Molecular Pathology in Vienna, Austria, he moved to the National Cancer Center of Singapore (NCCS) in late 1999 as…...
Yung-Chi Cheng, Ph.D.
Dr. Yung-Chi Cheng received his B.S. in chemistry from Tunghai University in Taiwan and his Ph.D. in biochemical pharmacology from Brown University. He then performed his postdoctoral work at Yale University from 1972 to 1974. Upon completing this work, Dr. Cheng joined the faculty of the Roswell Park Memorial Institute…...
Lei Zheng, M.D., Ph.D.
Lei Zheng, M.D., Ph.D. is Professor of Oncology and Surgery at the Johns Hopkins University School of Medicine. He is the Cancer Center and the Department of Oncology’s Assistant Director for Translational Research and Associate Cancer Center Director for Precision Medicine. He co-leads the precision medicine research and practice at…...
